| dbo:abstract
|
- BTG (früher British Technology Group) ist ein britisches Unternehmen, das sich auf die Lizenzierung und Vermarktung medizinischer Entwicklungen spezialisiert hat. Die Firma entstand aus der Fusion der National Research Development Corporation und des National Enterprise Board und ist an der Londoner Börse im FTSE 250 Index gelistet. (de)
- BTG Limited is an international specialist healthcare company that is developing and commercialising products targeting critical care, cancer and other disorders. The current name was adopted when the British Technology Group changed its name on 27 May 1998. BTG was a constituent of the FTSE 250 Index until it was acquired by Boston Scientific in August 2019. (en)
|
| dbo:foundingYear
| |
| dbo:industry
| |
| dbo:keyPerson
| |
| dbo:location
| |
| dbo:parentCompany
| |
| dbo:product
| |
| dbo:revenue
| |
| dbo:thumbnail
| |
| dbo:type
| |
| dbo:wikiPageExternalLink
| |
| dbo:wikiPageID
| |
| dbo:wikiPageLength
|
- 7444 (xsd:nonNegativeInteger)
|
| dbo:wikiPageRevisionID
| |
| dbo:wikiPageWikiLink
| |
| dbp:foundation
| |
| dbp:homepage
| |
| dbp:industry
| |
| dbp:keyPeople
|
- Garry Watts , Louise Makin , Duncan Kennedy (en)
|
| dbp:location
|
- London, United Kingdom (en)
|
| dbp:logo
| |
| dbp:logoSize
| |
| dbp:name
| |
| dbp:parent
| |
| dbp:products
|
- Development, manufacturing and commercialisation of specialty pharmaceuticals and interventional medicine in the areas of critical care, cancer and varicose veins. BTG also has a revenue stream from royalty payments on partnered products. (en)
|
| dbp:revenue
| |
| dbp:type
| |
| dbp:wikiPageUsesTemplate
| |
| dcterms:subject
| |
| rdf:type
| |
| rdfs:comment
|
- BTG (früher British Technology Group) ist ein britisches Unternehmen, das sich auf die Lizenzierung und Vermarktung medizinischer Entwicklungen spezialisiert hat. Die Firma entstand aus der Fusion der National Research Development Corporation und des National Enterprise Board und ist an der Londoner Börse im FTSE 250 Index gelistet. (de)
- BTG Limited is an international specialist healthcare company that is developing and commercialising products targeting critical care, cancer and other disorders. The current name was adopted when the British Technology Group changed its name on 27 May 1998. BTG was a constituent of the FTSE 250 Index until it was acquired by Boston Scientific in August 2019. (en)
|
| rdfs:label
|
- BTG (Medizintechnikunternehmen) (de)
- BTG (company) (en)
|
| owl:sameAs
| |
| prov:wasDerivedFrom
| |
| foaf:depiction
| |
| foaf:homepage
| |
| foaf:isPrimaryTopicOf
| |
| foaf:name
| |
| is dbo:wikiPageDisambiguates
of | |
| is dbo:wikiPageRedirects
of | |
| is dbo:wikiPageWikiLink
of | |
| is foaf:primaryTopic
of | |
